2014
DOI: 10.4103/1658-5127.141999
|View full text |Cite
|
Sign up to set email alerts
|

Multiple myeloma presenting as extensive limb gangrene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 7 publications
0
1
0
Order By: Relevance
“…The National Comprehensive Cancer Network (NCCN) recommends maintenance rituximab for patients who have partial or minor response to initial treatment. A randomized phase 3 trial reported that median progression-free survival (PFS) was longer with maintenance rituximab though statistical significance for this difference was not reached [ 10 ]. Furthermore, assessing the clinical response to induction therapy in this patient was difficult as irreversible gangrene occurred prior to chemotherapy administration.…”
Section: Discussionmentioning
confidence: 99%
“…The National Comprehensive Cancer Network (NCCN) recommends maintenance rituximab for patients who have partial or minor response to initial treatment. A randomized phase 3 trial reported that median progression-free survival (PFS) was longer with maintenance rituximab though statistical significance for this difference was not reached [ 10 ]. Furthermore, assessing the clinical response to induction therapy in this patient was difficult as irreversible gangrene occurred prior to chemotherapy administration.…”
Section: Discussionmentioning
confidence: 99%
“…[ 3 4 ] Hematological malignancies including leukemias, lymphomas, and myeloma are reported to be associated with digital ischemia. [ 5 6 7 ] Myeloproliferative disorders including chronic myeloid leukemia and essential thrombocythemia were previously reported to be associated with digital ischemia. [ 8 9 ] The proposed mechanism in these cases of digital gangrene was thrombocytosis.…”
mentioning
confidence: 99%